- Home
- EHAB
EHAB
Enhabit Inc.
as 05-20-2024 2:34pm EST
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | DALLAS |
| Market Cap: | 452.4M | IPO Year: | N/A |
| Target Price: | $10.46 | AVG Volume (30 days): | 649.9K |
| Analyst Decision: | Hold | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.12 - $14.59 | Next Earning Date: | 05-08-2024 |
| Revenue: | $1,043,600,000 | Revenue Growth: | -1.72% |
| Revenue Growth (this year): | 5.8% | Revenue Growth (next year): | 4.43% |
Share on Social Networks:
Stock Insider Trading Activity of Enhabit Inc. (EHAB)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Langham Ronald Leroy JR | EHAB | EVP Clinical Excel. & Strategy | Mar 1 '24 | Sell | $8.81 | 634 | $5,585.54 | 57,164 | SEC Form 4 |
Latest Enhabit Inc. News
EHAB Breaking Stock News: Dive into EHAB Ticker-Specific Updates for Smart Investing
Argus Research
8 hours ago
Daily – Vickers Top Buyers & Sellers for 05/20/2024
MT Newswires
6 days ago
Leerink Partners Upgrades Enhabit to Market Perform From Underperform, Price Target is $8.50
Simply Wall St.
8 days ago
Insider Spends US$82k Buying More Shares In Enhabit
GuruFocus.com
10 days ago
Enhabit Inc (EHAB) Reports Mixed Q1 2024 Results: Challenges and Strategic Adjustments Highlighted
MT Newswires
10 days ago
UBS Trims Price Target on Enhabit to $9 From $10, Keeps Neutral Rating
GlobeNewswire
11 days ago
AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
MT Newswires
11 days ago
Jefferies Downgrades Enhabit to Hold From Buy, Price Target at $8.75
Zacks
12 days ago